文章摘要
郑建洵.多发性骨髓瘤患者血清IL-6与β2-MG水平的变化及临床意义[J].实用中西医结合临床,2016,16(11):14-16
多发性骨髓瘤患者血清IL-6与β2-MG水平的变化及临床意义
Changes of serum Interleukin-6、?茁2-MG Levels in Patients with Multiple Myeloma and Its Clinical Significance
  
DOI:
中文关键词: 多发性骨髓瘤  白介素-6  ?茁2-微球蛋白  预后  影响因素
英文关键词: Multiple myeloma  Interleukin-6  ?茁2-microglobulin  Prognosis  Influencing factors
基金项目:
作者单位
郑建洵 福建中医药大学附属人民医院检验科 
摘要点击次数: 563
全文下载次数: 286
中文摘要:
      目的:探讨多发性骨髓瘤患者血清IL-6与?茁2-MG的变化及临床意义。方法:以本院2013年6月~2015年6月收治的60例多发性骨髓瘤患者为研究对象,以本院同期40例健康志愿者为对照组,用RIA法检测各组血清中IL-6与?茁2-MG表达水平,并随访观察。结果:MM组患者血清IL-6、?茁2-MG水平均显著高于对照组,差异均具有统计学意义(P<0.05)。ISS Ⅲ期患者IL-6、?茁2-MG水平均高于ISSⅠ期和ISSⅡ期患者(P<0.05)。MM患者初治组与复发难治组血清中IL-6、?茁2-MG的表达水平均明显高于对照组,差异有统计学意义(P<0.05)。与初治组相比,MM患者治疗有效组IL-6、?茁2-MG表达水平显著降低,差异有统计学意义(P<0.05)。MM患者复发难治组血清中IL-6、?茁2-MG的表达水平均明显高于初治组,差异有统计学意义(P<0.05)。结论:IL-6、?茁2-MG在多发性骨髓瘤的发生发展中起着重要作用,IL-6、?茁2-MG水平的升高与患者预后密切相关,可将IL-6、?茁2-MG作为判断多发性骨髓瘤病情评估、治疗效果和预后监测的重要指标。
英文摘要:
      Objective: To investigate the changes of serum IL-6、?茁2-MG in patients with multiple myeloma and its clinical significance. Methods: Sixty patients with multiple myeloma were enrolled from June 2008 to June 2015 in our hospital. Forty healthy volunteers were selected as control group.The levels of IL-6 and ?茁2-MG were measured by Radioimmunoassy (RIA). Results: The levels of IL-6 and ?茁2-MG in the MM group were significantly higher than those in the control group (P<0.05). The levels of IL-6 and ?茁2-MG which were higher than those of ISSⅠ and ISSⅡ (P<0.05). Serum IL-6 and ?茁2-MG expression levels in first-treated group and recurrence group of paients with MM were significantly higher than those of control group, and the difference was statistically significant (P<0.05). Compared with first-treated group, the IL-6 and ?茁2-MG expression level of alleviated group were significantly lower than in the early treated group, and the difference was statistically significant (P<0.05), the IL-6 and ?茁2-MG expression levels in recurrence group were significantly higher than those of first-treated group (P<0.05). Conclusion: IL-6 and ?茁2-MG play an important role in the development and progression of multiple myeloma, elevation of IL-6 and ?茁2-MG are closely related to the prognosis of patients, IL-6 and ?茁2-MG can be used as an important index to judge the development and prognosis of multiple myeloma.
查看全文   查看/发表评论  下载PDF阅读器
关闭
手机扫一扫看
分享按钮